Matrix bound SFD mutant TIMP-3 is more stable than wild type TIMP-3

Background: Sorsby’s fundus dystrophy (SFD) is a degenerative retinopathy characterised by accumulation of mutant TIMP-3 protein in Bruch’s membrane. Aim: To compare the stability of matrix bound SFD mutant TIMP-3s with wild type TIMP-3. Methods: COS-7 cells were transfected with plasmids containing wild type, Ser 181, Gly-167, Ser-156, and Tyr-168 TIMP-3 cDNA. The cells and their matrices were subsequently harvested and homogenised. After measuring the bound wild type and SFD mutant TIMP-3 concentrations by ELISA, aliquots of the homogenates were heated to 100°C. The rates of denaturation of the TIMP proteins at this temperature were monitored by reverse zymography. Results: Over a period of 24 h at 100°C the biological activity of both wild type and SFD mutant TIMP-3 was lost. Over a period of 6 h at this temperature the biological activity of the SFD mutant TIMP-3s was fully retained whereas that of the wild type TIMP-3 was lost. Conclusion: Matrix bound SFD mutant TIMP-3s are thermodynamically more stable than wild type. This may explain why SFD starts earlier in life than age related macular degeneration.

[1]  A. Dick,et al.  Tissue inhibitor of metalloproteinase-3 differentially binds to components of Bruch’s membrane , 2006, British Journal of Ophthalmology.

[2]  F. J. Matthews,et al.  Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. , 2006, Biochimica et biophysica acta.

[3]  N. Brown,et al.  Sorsby's fundus dystrophy mutations impair turnover of TIMP-3 by retinal pigment epithelial cells. , 2005, Human molecular genetics.

[4]  D. Easty,et al.  Sorsby's fundus dystrophy mutant tissue inhibitors of metalloproteinase‐3 induce apoptosis of retinal pigment epithelial and MCF‐7 cells , 2002, FEBS letters.

[5]  V. Sheffield,et al.  Novel mutation in the TIMP3 gene causes Sorsby fundus dystrophy. , 2002, Archives of ophthalmology.

[6]  D. Easty,et al.  Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells , 2002, The British journal of ophthalmology.

[7]  I. Griffiths,et al.  Clinical features of a novel TIMP-3 mutation causing Sorsby's fundus dystrophy: implications for disease mechanism , 2001, The British journal of ophthalmology.

[8]  G. Murphy,et al.  Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase. , 2001, Biochemical and biophysical research communications.

[9]  V. Knäuper,et al.  Localization of the Death Domain of Tissue Inhibitor of Metalloproteinase-3 to the N Terminus , 2000, The Journal of Biological Chemistry.

[10]  A. Bird,et al.  TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. , 2000, Investigative ophthalmology & visual science.

[11]  M. Kamei,et al.  TIMP-3 in Bruch's membrane: changes during aging and in age-related macular degeneration. , 1999, Investigative ophthalmology & visual science.

[12]  A. Milam,et al.  Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby’s fundus dystrophy or retinitis pigmentosa , 1998, The British journal of ophthalmology.

[13]  M. Barker,et al.  Localization of the Functional Domains of Human Tissue Inhibitor of Metalloproteinases-3 and the Effects of a Sorsby’s Fundus Dystrophy Mutation* , 1998, The Journal of Biological Chemistry.

[14]  J. Haines,et al.  Exclusion of TIMP3 as a candidate locus in age-related macular degeneration. , 1997, Investigative ophthalmology & visual science.

[15]  Y. Shi,et al.  Computational Sequence Analysis of the Tissue Inhibitor of Metalloproteinase Family , 1997, Journal of protein chemistry.

[16]  E. Zrenner,et al.  Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies. , 1997, Investigative ophthalmology & visual science.

[17]  M. Klein,et al.  Sorsby fundus dystrophy. A family with the Ser181Cys mutation of the tissue inhibitor of metalloproteinases 3. , 1996, Archives of ophthalmology.

[18]  H. Stöhr,et al.  A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy. , 1996, Journal of medical genetics.

[19]  H. Stöhr,et al.  A novel Ser156Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy with unusual clinical features. , 1995, Human molecular genetics.

[20]  R. Pruett,et al.  Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy , 1994, Nature Genetics.

[21]  E. Ives,et al.  Sorsby's fundus dystrophy is genetically linked to chromosome 22q13–qter , 1994, Nature Genetics.

[22]  L. Pallanck,et al.  The 21-kDa protein is a transformation-sensitive metalloproteinase inhibitor of chicken fibroblasts. , 1991, The Journal of biological chemistry.

[23]  A. Bird,et al.  Sorsby's fundus dystrophy. A clinical study. , 1989, Ophthalmology.

[24]  A. Bird,et al.  Sorsby's pseudoinflammatory macula dystrophy—Sorsby's fundus dystrophies , 1988, Eye.

[25]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[26]  Vivek Trikha,et al.  Clinical Study , 1961, Acta neurologica Scandinavica.

[27]  A. Sorsby,et al.  A FUNDUS DYSTROPHY WITH UNUSUAL FEATURES (Late onset and dominant inheritance of a central retinal lesion showing oedema, haemorrhage and exudates developing into generalised choroidal atrophy with massive pigment proliferation) , 1949 .

[28]  M. Pericak-Vance,et al.  Exclusion of TIMP 3 as a Candidate Locus in Age-Related Macular Degeneration , 2005 .

[29]  J. Greenberg,et al.  SORSBY'S FUNDUS DYSTROPHY: A South African Family with a Point Mutation on the Tissue Inhibitor of Metalloproteinases‐3 Gene on Chromosome 22 , 1995, Retina.

[30]  B. Olsen,et al.  Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. , 1994, Genomics.

[31]  A. Sorsby,et al.  A fundus dystrophy with unusual features. , 1949, The British journal of ophthalmology.